FDA rejects drug from Disc Medicine, early recipient of commissioner’s voucherÂ
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Moderna’s president weighs in on FDA’s decision not to review its flu vaccine
Food and Drug Administration officials told Moderna in August that they would review its application for a new…
Calidi RedTail BiTE solid tumor data at AACR-IO
Calidi Biotherapeutics (NYSE American: CLDI) will present a late‑breaking abstract at the AACR…
Prasad overruled FDA staff to reject Moderna flu vaccine application
WASHINGTON — Top Food and Drug Administration official Vinay Prasad overruled the agency’s reviewers when he refused to accept…
CVS Health (CVS) earnings Q4 2025
A pedestrian walks by a CVS store in Greenbrae, California, on July 31, 2025. Justin Sullivan | Getty…
FDA rejects Regenxbio’s MPS II rare-disease gene therapy
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Learning about longevity from long-lived animals
The Turritopsis dohrnii is a small, bell-shaped jellyfish found in temperate and tropical waters. It has stinging tentacles…
Eli Lilly (LLY) earnings Q4 2025
Eli Lilly on Wednesday posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand…
Pfizer’s monthly obesity injection drove shows promise in trial
Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it…
Pfizer (PFE) earnings Q4 2025
Albert Bourla, CEO of Pfizer, speaking on Squawk on the Street at the World Economic Forum in Davos,…
Eli Lilly CEO David Ricks talks Medicare coverage of obesity pills
Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major…
Eli Lilly plans $3.5 billion Pennsylvania plant for obesity drugs
Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik…